Vzarii Therapeutics (@vzariitx) 's Twitter Profile
Vzarii Therapeutics

@vzariitx

Developing innovative gene therapy platform technologies targeting mitochondrial dysfunction 🧬

ID: 1594627531109548038

linkhttp://vzariitherapeutics.com calendar_today21-11-2022 09:43:41

13 Tweet

22 Followers

11 Following

Big Ideas (@ei_bigideas) 's Twitter Profile Photo

Age-related macular degeneration (AMD) is a neurodegenerative retinal disease affecting up to 10% of adults over 65 years. At BIG IDEAS – 24 November hear how Vzarii has developed innovative gene therapies that target late-stage dry AMD Enterprise Ireland #GLOBALAMBITION

Age-related macular degeneration (AMD) is a neurodegenerative retinal disease affecting up to 10% of adults over 65 years. At BIG IDEAS – 24 November hear how Vzarii has developed innovative gene therapies that target late-stage dry AMD <a href="/Entirl/">Enterprise Ireland</a> #GLOBALAMBITION
Enterprise Ireland (@entirl) 's Twitter Profile Photo

12 investor-ready start-ups will pitch their new technology solutions to investors at Big Ideas today. Listen back to our Director of Commercialisation Deirdre Glenn speaking to Joe Lynam on @newstalkFM to find out more: rebrand.ly/NewstalkBigIde…

12 investor-ready start-ups will pitch their new technology solutions to investors at <a href="/EI_bigideas/">Big Ideas</a> today.
 
Listen back to our Director of Commercialisation Deirdre Glenn speaking to <a href="/JoeBLynam/">Joe Lynam</a> on @newstalkFM to find out more: rebrand.ly/NewstalkBigIde…
Big Ideas (@ei_bigideas) 's Twitter Profile Photo

Our host Anton Savage has kicked off Big Ideas 2022. Watch Live now to hear about the disruptive Irish technologies that will impact our future:rebrand.ly/BigIdeas #Bigideas2022 #GlobalAmbition Enterprise Ireland

Our host <a href="/AntonSavageShow/">Anton Savage</a> has kicked off Big Ideas 2022. 

Watch Live now to hear about the disruptive Irish technologies that will impact our future:rebrand.ly/BigIdeas

#Bigideas2022 #GlobalAmbition <a href="/Entirl/">Enterprise Ireland</a>
Big Ideas (@ei_bigideas) 's Twitter Profile Photo

Age-related macular degeneration (AMD) affects up to 10% of adults over the age of 65. Vzarii Therapeutics has developed first in class innovative platform gene therapies that target late-stage dry AMD to restore mitochondrial disfunction and improve retinol function. #BigIdeas2022

Age-related macular degeneration (AMD) affects up to 10% of adults over the age of 65.

<a href="/VzariiTX/">Vzarii Therapeutics</a> has developed first in class innovative platform gene therapies that target late-stage dry AMD to restore mitochondrial disfunction and improve retinol function.

#BigIdeas2022
Loretto C (@lorettocal) 's Twitter Profile Photo

Further evidence supporting targeting mitochondrial dysfunction as a novel potential therapeutic strategy for multiple eye diseases #TrinityCollegeDublin #amd #neurodegenerativediseases

Trinity Innovation KnEx (@tcd_innovation) 's Twitter Profile Photo

6 spinouts ⁦Vzarii Therapeutics⁩ #parvalis ⁦@AilseVax⁩ from ⁦Trinity College Dublin⁩ and Probmet LEP Biomedical Renovate Pharma from ⁦RCSI⁩ presenting at Bioequity Europe next week ⁦Enterprise Ireland⁩ ⁦KTI Connect⁩ ⁦Qubis⁩ siliconrepublic.com/start-ups/iris…